MedPath

Comparing standard blood oxygen measures to a new device in humans under changing oxygen conditions

Phase 1
Conditions
Stroke
Global Hypoxia
Cardiac Bypass Related Embolism
Global Ischemia
Neurological - Other neurological disorders
Stroke - Haemorrhagic
Stroke - Ischaemic
Cardiovascular - Other cardiovascular diseases
Registration Number
ACTRN12620000691943
Lead Sponsor
A/Prof. Shieak Tzeng
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
4
Inclusion Criteria

18-50 years old
Generally healthy
Non-smoker
People with a BMI 18.5-30 kg m^-2

Exclusion Criteria

History of migraines
History of respiratory or cardiovascular disease or specific renal impairment.
Currently taking diuretics, antacids, proton pump inhibitors, or histamine blockers.
Smoking
Under 18 or over 50 years of age
History of stroke or other neurological conditions
Pregnancy
A contrast enhanced medical scan in the past week
There will also be a set of within-trial cessation criteria: a resting heart rate above 140 bpm, a peripheral O2 saturation below 70%, subject intolerance or request, sudden headache or nausea, or mental abnormalities as assessed by a clinician (i.e.: confusion, incoordination of motor skills).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath